Medical Condition: Sjogren’s Syndrome
Facility/Clinic: Accellacare
Age: 18 or older
Gender: Male/Female
Description: The purpose of this study is to evaluate the safety, activity and side effects of a new research drug compared to a placebo for people diagnosed with Sjogren’s Syndrome. This research study may be an option if you:
- Have been diagnosed with Sjogren’s Syndrome
- Have not been diagnosed with deep vein thrombosis or arterial thromboembolism within the last 2 years
- Require treatment with anticoagulant drugs
Other criteria apply. Please make sure to discuss this study with a member of our research staff to ensure this research study is a good fit for you. Qualified participants will receive all study-related care and study medication at no cost.
Enrollment: Open
Patient Commitment Duration: Approximately 56 weeks
Number of visits in study: Approximately 15 clinic visits
Patient Compensation: Financial compensation will be provided for time and travel expenses.
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.